Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

SEER

Seer (SEER)

Seer Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SEER

1 2 3 4 5 6 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
08/05/2024	22h35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SEER	Seer Inc
08/05/2024	22h15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
08/05/2024	22h05	GlobeNewswire Inc.	Seer Reports First Quarter 2024 Financial Results	NASDAQ:SEER	Seer Inc
08/05/2024	22h03	GlobeNewswire Inc.	Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions	NASDAQ:SEER	Seer Inc
23/04/2024	22h05	GlobeNewswire Inc.	Seer to Report First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:SEER	Seer Inc
06/03/2024	22h14	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SEER	Seer Inc
29/02/2024	22h15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
29/02/2024	22h05	GlobeNewswire Inc.	Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook	NASDAQ:SEER	Seer Inc
23/02/2024	23h30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SEER	Seer Inc
21/02/2024	22h05	GlobeNewswire Inc.	Seer to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:SEER	Seer Inc
08/02/2024	03h05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SEER	Seer Inc
06/02/2024	14h00	GlobeNewswire Inc.	Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery	NASDAQ:SEER	Seer Inc
01/02/2024	22h05	GlobeNewswire Inc.	Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024	NASDAQ:SEER	Seer Inc
03/01/2024	14h52	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SEER	Seer Inc
22/12/2023	22h10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
21/12/2023	22h05	GlobeNewswire Inc.	Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference	NASDAQ:SEER	Seer Inc
17/11/2023	22h58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
10/11/2023	15h00	GlobeNewswire Inc.	Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum	NASDAQ:SEER	Seer Inc
08/11/2023	15h00	GlobeNewswire Inc.	Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500	NASDAQ:SEER	Seer Inc
07/11/2023	22h25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SEER	Seer Inc
07/11/2023	22h18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
07/11/2023	22h05	GlobeNewswire Inc.	Seer Reports Third Quarter 2023 Financial Results	NASDAQ:SEER	Seer Inc
01/11/2023	14h00	GlobeNewswire Inc.	Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program	NASDAQ:SEER	Seer Inc
19/10/2023	22h05	GlobeNewswire Inc.	Seer to Report Third Quarter 2023 Financial Results on November 7, 2023	NASDAQ:SEER	Seer Inc
08/09/2023	22h05	GlobeNewswire Inc.	Seer to Participate in Upcoming September Investor Conferences	NASDAQ:SEER	Seer Inc
08/08/2023	22h21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SEER	Seer Inc
08/08/2023	22h15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc
08/08/2023	22h05	GlobeNewswire Inc.	Seer Reports Second Quarter 2023 Financial Results	NASDAQ:SEER	Seer Inc
27/07/2023	22h05	GlobeNewswire Inc.	Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference	NASDAQ:SEER	Seer Inc
21/07/2023	22h29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SEER	Seer Inc

Showing the most relevant articles for your search:NASDAQ:SEER

1 2 3 4 5 6 Next >>

Deutsche Telekom

Invesco QQQ Trust Series 1

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen